Prevalence of Weight Related Complications Across Diverse Weight Classifications - A Large Study in India, Pakistan, Philippines and Vietnam
NCT ID: NCT06843473
Last Updated: 2025-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1165 participants
OBSERVATIONAL
2025-03-18
2025-10-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific
NCT05250427
Beneficial Effects of Dietary and Lifestyle Change in Overweight and Obese Subjects
NCT05447351
Effect of Obesity Among COVID-19 Patients in Critical Care Settings
NCT04674553
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
NCT03141008
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1
Participants will be assessed for obesity-related complications, including measurement of Body Mass Index (BMI)
No treatment given
No treatment given
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No treatment given
No treatment given
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female aged 18 years or older at the time of signing informed consent.
* Presence of at least one Weight-related complication.
Exclusion Criteria
* Pregnant women and individuals with recent weight loss due to illness, defined as more than 5 percent (%) weight loss in the past 6 months.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novo Nordisk A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Transparency (dept. 2834)
Role: STUDY_DIRECTOR
Novo Nordisk A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bangalore Diabetes Centre
Bangalore, Karnataka, India
Belgaum Diabetes Centre
Belagavi, Karnataka, India
KGN Diabetes and Endocrinology Centre
Mumbai, Maharashtra, India
AIIMS,Delhi
New Delhi, National Capital Territory of Delhi, India
All India Institute of Medical Sciences_Delhi
Ansārinagar, New Delhi, India
Endeavour Clinic - Centre of Diabetes and Endocrinology
Bhubaneswar, Odisha, India
IPGME&R and SSKM Hospital
Kolkata, West Bengal, India
Pakistan Institute of Medical Sciences
Islamabad, , Pakistan
Aga Khan University Hospital
Karachi, , Pakistan
National Defence Hospital
Lahore, , Pakistan
National Hospital Lahore
Lahore, , Pakistan
Mukhtar A Sheikh Hospital Multan
Multan, , Pakistan
Peshawar General Hospital
Peshawar, , Pakistan
Asian Hospital and Medical Center
Metro Manila, San Juan, Philippines
Tam Anh TP. Ho Chi Minh General Hospital
Ho Chi Minh City, Tan Binh, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1308-4250
Identifier Type: OTHER
Identifier Source: secondary_id
DAS-8265
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.